Image_5_CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis.TIF
C3 Glomerulopathy (C3G) and Immune Complex-Mediated Membranoproliferative glomerulonephritis (IC-MPGN) are rare diseases characterized by glomerular deposition of C3 caused by dysregulation of the alternative pathway (AP) of complement. In approximately 20% of affected patients, dysregulation is driven by pathogenic variants in the two components of the AP C3 convertase, complement C3 (C3) and Factor B (CFB), or in complement Factor H (CFH) and Factor I (CFI), two genes that encode complement regulators. Copy number variations (CNVs) involving the CFH-related genes (CFHRs) that give rise to hybrid FHR proteins also have been described in a few C3G patients but not in IC-MPGN patients. In this study, we used multiplex ligation-dependent probe amplification (MLPA) to study the genomic architecture of the CFH-CFHR region and characterize CNVs in a large cohort of patients with C3G (n = 103) and IC-MPGN (n = 96) compared to healthy controls (n = 100). We identified new/rare CNVs resulting in structural variants (SVs) in 5 C3G and 2 IC-MPGN patients. Using long-read single molecule real-time sequencing (SMRT), we detected the breakpoints of three SVs. The identified SVs included: 1) a deletion of the entire CFH in one patient with IC-MPGN; 2) an increased number of CFHR4 copies in one IC-MPGN and three C3G patients; 3) a deletion from CFHR3-intron 3 to CFHR3-3′UTR (CFHR34–6Δ) that results in a FHR3-FHR1 hybrid protein in a C3G patient; and 4) a CFHR31–5-CFHR410 hybrid gene in a C3G patient. This work highlights the contribution of CFH-CFHR CNVs to the pathogenesis of both C3G and IC-MPGN.
History
References
- https://doi.org//10.1159/000414943
- https://doi.org//10.4049/jimmunol.1402770
- https://doi.org//10.1016/j.matbio.2016.09.002
- https://doi.org//10.1681/ASN.2013050453
- https://doi.org//10.1073/pnas.1717600115
- https://doi.org//10.1093/hmg/ddg363
- https://doi.org//10.1172/jci71866
- https://doi.org//10.1038/nrneph.2014.217
- https://doi.org//10.4049/jimmunol.1600483
- https://doi.org//10.1007/s002510050534
- https://doi.org//10.3389/fimmu.2018.02329
- https://doi.org//10.1038/nrg1767
- https://doi.org//10.1016/s0140-6736(10)60670-8
- https://doi.org//10.1073/pnas.1219260110
- https://doi.org//10.1074/jbc.M112.364471
- https://doi.org//10.1371/journal.pone.0060352
- https://doi.org//10.1038/ki.2013.340
- https://doi.org//10.1038/ng1890
- https://doi.org//10.1681/asn.2017030258
- https://doi.org//10.1016/j.molimm.2016.01.010
- https://doi.org//10.1038/ng.2892
- https://doi.org//10.1371/journal.pgen.0010049
- https://doi.org//10.1002/humu.21256
- https://doi.org//10.1681/asn.2012020166
- https://doi.org//10.1681/asn.2016030343
- https://doi.org//10.1038/ki.2013.348
- https://doi.org//10.1111/imr.12477
- https://doi.org//10.1182/blood-2009-05-221549
- https://doi.org//10.1146/annurev.iy.04.040186.002443
- https://doi.org//10.2215/CJN.02210310
- https://doi.org//10.1053/j.ajkd.2015.03.040
- https://doi.org//10.4049/jimmunol.1701695
- https://doi.org//10.1074/jbc.M110.211839
- https://doi.org//10.1038/gim.2015.30
- https://doi.org//10.1038/ki.2012.63
- https://doi.org//10.1016/j.semnephrol.2011.06.005
- https://doi.org//10.1016/j.molimm.2013.06.001
- https://doi.org//10.1016/j.kint.2017.04.025
- https://doi.org//10.1172/jci68280
- https://doi.org//10.3389/fimmu.2019.00853
- https://doi.org//10.1016/j.molimm.2016.07.007
- https://doi.org//10.3389/fimmu.2020.607211
- https://doi.org//10.2215/cjn.07900811
- https://doi.org//10.1371/journal.pgen.1002079
Usage metrics
Read the peer-reviewed publication
Categories
- Gene and Molecular Therapy
- Gene Expression (incl. Microarray and other genome-wide approaches)
- Genetics
- Genetically Modified Animals
- Livestock Cloning
- Developmental Genetics (incl. Sex Determination)
- Epigenetics (incl. Genome Methylation and Epigenomics)
- Biomarkers
- Genomics
- Genome Structure and Regulation
- Genetic Engineering